Brevia Health has appointed Jonathan Mogford to its Advisory Board who brings a career’s experience of health, life sciences and regulation, including more than 10 years corporate executive leadership at MHRA.
Brevia Health has appointed Jonathan Mogford to its Advisory Board who brings a career’s experience of health, life sciences and regulation, including more than 10 years corporate executive leadership at MHRA.
In an era marked by unprecedented advances in technology, the intersection of AI, healthcare, and life sciences has paved the way for improved medical practice, research, and patient care.
Brevia Health has deepened our vaccines expertise with the appointment of Nick Lowen as an Associate with over 30 years’ life sciences experience including serving as Vice President, Commercial Strategic Projects at GSK.
Brevia Health has appointed Mark Bassett as an Associate. Mark brings over 35 years of experience in healthcare advisory and leadership roles, including as Group Director of Public Policy at Bupa Group.
NHS England announced an updated Vaccination Strategy following calls from pharmaceutical companies and trade bodies for a national Vaccination Strategy to tackle issues of accessibility, misinformation, and distrust around vaccination.
In January 2024, the Shadow Secretary of State for Health and Social Care and Shadow Secretary of State for Science, Innovation and Technology launched Labour’s new Life Sciences Strategy. The new plan seeks to reform and modernise the NHS as well as capture the economic potential in the life sciences sector.
The UK’s political parties held their annual Party Conferences in September and October this year. They provided an opportunity to promote their policies and outline their respective political agendas ahead of the upcoming general election.
The UK Health Security Agency (UKHSA) has agreed to a deal for millions of life-saving vaccines to be produced in the UK if a future influenza pandemic is ever declared.
Brevia Health has appointed Jonathan Mogford to its Advisory Board who brings a career’s experience of health, life sciences and regulation, including more than 10 years corporate executive leadership at MHRA.
